Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|April 25, 2022
Variation in Cancer Incidence Rates Among Non-Hispanic Black Individuals Disaggregated by Nativity and Birthplace, 2005-2017: A Population-Based Cancer Registry AnalysisAdana A M Llanos, Jie Li, Jennifer Tsui, et al.
Journal of the National Cancer Institute|April 24, 2025
Historical redlining and mortality in children, adolescents, and young adults with cancer in California, 2000-2019Kristine A Karvonen, Annie Vu, Katherine Lin, et al.
Clinical Immunology (Orlando, Fla.)|July 23, 2023
Behçet's patients' response to COVID-19 vaccinationBindi Gokani, Sarah Sacoor, Georgia R Leisegang, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2012
Phase I trial of pomalidomide given for patients with advanced solid tumorsMatthew M Cooney, Charles Nock, Joseph Bokar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Disparities in Hepatocellular Carcinoma Incidence in California: An UpdateMeera Sangaramoorthy, Juan Yang, Mindy C DeRouen, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2012
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumorsJoanna M Brell, Smitha S Krishnamurthi, Linda Rath, et al.
Investigational New Drugs|May 13, 2008
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principlesSharon L Sanborn, Matthew M Cooney, Afshin Dowlati, et al.
Investigational New Drugs|November 18, 2008
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumorsSharon L Sanborn, Joseph Gibbons, Smitha Krishnamurthi, et al.
Optics Express|August 6, 2020
Effect of light scattering on upconversion photoluminescence quantum yield in microscale-to-nanoscale materialsCallum M S Jones, Nikita Panov, Artiom Skripka, et al.
American Journal of Clinical Oncology|October 8, 2008
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancerTimothy J Kinsella, Yuji Seo, Joseph Willis, et al.
Pageof 4